论文信息 - Rationale and design of the expanded combination of evolocumab plus empagliflozin in diabetes: EXCEED-BHS3 trial - 字舞流文

Rationale and design of the expanded combination of evolocumab plus empagliflozin in diabetes: EXCEED-BHS3 trial

F. Zimetti | E. Muscelli | A. Kontush | A. Sposito | T. Quinaglia | I. Zanotti | W. Nadruz | I. Breder | D. Munhoz | L. F. Carvalho | I. Bonilha | Jessica Cunha Breder | Sheila T. Kimura Medorima | Daniela C Oliveira | Helison R. P. do Carmo | Camila Moreira | S. T. K. Medorima